project id: TCGA-CESC; case submitter id: TCGA-EK-A2PI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.2; age at index: 44; days to birth: -16324; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1965; age at diagnosis: 16324; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 586.0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 881; initial weight: 50.0; oct embedded: false; preservation method: Unknown; sample id: e42a980a-8189-41ad-b5ff-10181229f8b2; sample submitter id: TCGA-EK-A2PI-01A; portion id: 833e61cc-04d5-4f89-a4c7-a33ffbc9011a; portion submitter id: TCGA-EK-A2PI-01A-11; slide id: b85ef208-7541-45f3-a5b4-6acf3a1124a3; slide submitter id: TCGA-EK-A2PI-01A-01-TS1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 18.0; percent tumor cells: 50.0; percent tumor nuclei: 68.0; section location: TOP;